Percent of health facilities with uninterrupted stocks of vaccines, oral rehydration salts, zinc, antimalarial and antiretroviral agents and injectable gentamicin in the past 3 months
Percent of health facilities with uninterrupted stocks of vaccines, oral rehydration salts, zinc, antimalarial and antiretroviral agents and injectable gentamicin in the past 3 months.
Number of facilities with stocks of vaccines, oral rehydration salts, zinc, antimalarial and antiretroviral agents and injectable gentamicin in the past 3 months.
All facilities providing child health services.
Commodity type, facility type, geographic location, managing authority, programme.
Stock out data may also refer to other specific time periods (1 month, 3 months).
Data on the availability of vaccines, oral rehydration salts, zinc, antimalarial and antiretroviral agents and injectable gentamicinare collected from a survey of facilities. Availability is reported as the percentage of medicine outlets where a particular medicine was found on the day of the survey. Health facility reports may also include stockouts indicators but require regular independent verification.
Health facility survey
SARA (service availability and readiness assessment)
SPA (service provision assessment)
Routine logistic information system
This indicator measures the availability of physical resources at the facility. Access to vaccines, oral rehydration salts, zinc, antimalarial and antiretroviral agents and injectable gentamicin and are intended to be available within the context of functioning health system at all times and in adequate amounts.
Service access and availability, Essential medicines, Commodities, Supply chain and logistics, Pediatric care, Newborn health, Child health, Immunization, Nutrition, HIV care, Respiratory disease, Diarrheal disease, Malaria
World Health Organization (WHO). Consultation on Improving Measurement of the Quality of Maternal, Newborn and Child Care in Health Facilities.; 2013. http://apps.who.int/iris/bitstream/10665/128206/1/9789241507417_eng.pdf
